<SEC-DOCUMENT>0001213900-26-059237-index.html : 20260520
<SEC-HEADER>0001213900-26-059237.hdr.sgml : 20260520
<ACCEPTANCE-DATETIME>20260520071857
ACCESSION NUMBER:		0001213900-26-059237
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260520
DATE AS OF CHANGE:		20260520

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vaxart, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35285
		FILM NUMBER:		261001393

	BUSINESS ADDRESS:	
		STREET 1:		310 UTAH AVENUE, SUITE 150
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		BUSINESS PHONE:		(650) 550-3500

	MAIL ADDRESS:	
		STREET 1:		310 UTAH AVENUE, SUITE 150
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aviragen Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160413

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>ea0291645-defa14a_vaxart.htm
<DESCRIPTION>SOLICITING MATERIAL PURSUANT TO 240.14A-12
<TEXT>
Document 1 - file: ea0291645-defa14a_vaxart.htm

</DOCUMENT>
</SEC-DOCUMENT>